Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ReNeuron
Biotech
ReNeuron leaving AIM exchange after missing fundraising goal
The stem cell biotech is letting go of its listing after money troubles persuaded it to free itself from the costs and obligations of the exchange.
Nick Paul Taylor
Aug 30, 2024 10:30am
ReNeuron lays off 40% of staff to buy time for exosome pivot
Jan 19, 2023 8:25am
ReNeuron shares clinical data on stem cell vision loss therapy
Oct 14, 2019 8:25am
ReNeuron climbs on updated vision loss cell therapy data
Apr 26, 2019 9:07am
ReNeuron stem cell test helps stroke patients but misses endpoint
Dec 5, 2016 6:50am
